Affordable Access

deepdyve-link
Publisher Website

[Prophylaxis and therapy for atrial fibrillation after general thoracic surgery].

Authors
  • Karagiannidis, C
  • Meissner, A
  • Koryllos, A
  • Windisch, W
  • Strassmann, S
Type
Published Article
Journal
Zentralblatt für Chirurgie
Publication Date
Sep 01, 2014
Volume
139 Suppl 1
Identifiers
DOI: 10.1055/s-0034-1383002
PMID: 25264722
Source
Medline
License
Unknown

Abstract

Following thoracic surgery atrial fibrillation (AF) frequently occurs in 12 to 44 % of cases postoperatively and is related to an increased morbidity and mortality. In 2011, the Society of Thoracic Surgeons of the United States published guidelines for the prophylaxis and treatment of postoperative AF. High evidence levels are provided for continuing β-blocker treatment despite its known negative inotropic effects. Alternatively, the calcium channel blocker diltiazem, or amiodarone for patients without pneumonectomy are recommended for prophylactic therapy. For rate control of AF occurring post surgery, not only selective β1-blockers, calcium channel blockers, but also magnesium or digoxin are suitable in haemodynamically stable patients. Amiodarone, β1-blockers and flecainide are preferred for rhythm control in case of haemodynamic stability in regard to possible side effects and contraindications. In contrast, electrical cardioversion is indicated in those patients with haemodynamic instability. Persistent AF of > 48 hours is a target for anticoagulation treatment depending on the individual aspects of the patient and in accordance to the CHADS2 score. The present review article further discusses the evidence for the recommended medical therapy and treatment strategies.

Report this publication

Statistics

Seen <100 times